Chemoradiation with Novel Agents for Rectal Cancer
- 1 May 2002
- journal article
- review article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 2 (1), 24-30
- https://doi.org/10.3816/ccc.2002.n.008
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- NF-κB signaling pathway as a target for human tumor radiosensitizationSeminars in Radiation Oncology, 2001
- Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and RadiationCancer Biotherapy & Radiopharmaceuticals, 1999
- Enhancement of Tumor Response to -Radiation by an Inhibitor of Cyclooxygenase-2 EnzymeJNCI Journal of the National Cancer Institute, 1999
- Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancerThe Lancet, 1997
- Epidermal Growth Factor Receptor Family and ChemosensitizationJNCI Journal of the National Cancer Institute, 1997
- Enhanced radiosensitivity by inhibition of nuclear factor kappaB activation in human malignant glioma cellsInternational Journal of Radiation Biology, 1997
- Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panelBiochemical Pharmacology, 1996
- Irradiation-enhanced Binding of Carboplatin to DNAInternational Journal of Radiation Biology, 1995
- Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional TrialJNCI Journal of the National Cancer Institute, 1994
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966